Cyclerion Share Price

Cyclerion Share Price

NASDAQ: CYCN | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cyclerion Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Cyclerion Share Price Chart

$0.00$0.00
L
Show Current Price
H

Cyclerion Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.03
Revenue (TTM)
$2.07B
Return On Equity (TTM)
-131.85%
Profit Margin
-170.53%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-79.59%

Cyclerion Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.88$1.03$0.00$0.00
Net Profit-$0.98-$0.80-$3.18-$1.76
Net Profit Margin-111.36%-77.67%N/AN/A
Income ChangeN/A18.37%-297.50%44.65%

Cyclerion Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.30$0.00$2.00$2.07
Net Profit-$44.08-$5.26-$3.06-$3.53
Net Profit Margin-14693.33%N/A-153.00%-170.53%
Income ChangeN/A88.07%41.83%-15.36%

Cyclerion Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets5.355.355.353.26
Current Assets4.644.238.0214.82
Total Assets9.999.5813.3718.08
Non Current Liabilities0.00.00.00.0
Current Liabilities0.90.732.097.63
Total Liabilities0.90.732.097.63
Shareholders' Equity9.098.8511.2910.45

Cyclerion Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-3.31-4.33-21.25-40.61
Investing0.00.010.40.0
Financing3.320.05.020.03

Corporate Actions

Split
Ex-date: 09 Sep 2026

Split
Ex-date: 16 May 2023

About Cyclerion

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Cyclerion Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Cyclerion Share Price FAQs